Company Description
MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada.
It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist.
The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Country | AZ |
Founded | 2007 |
Industry | Pharmaceutical Retailers |
Sector | Healthcare |
Employees | 279 |
Contact Details
Address: 4720 E Cotton Gin Loop, Suite 220 Phoenix, Arizona 85040 United States | |
Phone | 1.877.830.0826 |
Stock Details
Ticker Symbol | MDVLQ |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001402479 |
Employer ID | 90-0772394 |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Emilia Keric | Senior Vice President and General Counsel |
Joan O'Rourke | President of SpotRx |
Brian Schlerf | Corporate Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 21, 2024 | 25-NSE | Filing |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 8, 2024 | 8-K | Current Report |
Feb 6, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Feb 2, 2024 | 8-K | Current Report |
Jan 23, 2024 | 8-K | Current Report |
Nov 17, 2023 | 8-K | Current Report |
Nov 15, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
Nov 14, 2023 | 8-K | Current Report |
Aug 18, 2023 | 8-K | Current Report |